AIRCRAFT INTERIOR OEM A I R C R A F T F L O O R I N G • Meet aircraft flammability requirements (FAA) • Provide flame retardance and smoke mitigation • Maintain physical properties • Control viscosity and allow enhanced processability • Retain product integrity as contaminant free • Provide product traceability • Provided strong global EHS and regulatory support to minimize risk • Offered a solution to improve quality consistency and control viscosity • Enhanced mixing capability and improved processing temperature and imprint hold • Allowed greater security of supply with multiple manufacturing locations • Provided an integrated solution of plastisols and pigment dispersions that met traceability requirements with JIT delivery KEY REQUIREMENTS QUALITY + PERFORMANCE WHY AVIENT?

Schuering Page 77 Appliance 5% Building & Construction 3% Wire & Cable Electrical & Electronics Consumer 21% Industrial 24% HealthCare 21% Transportation 17% 2011 Revenue: $1.0 Billion2011 Revenue: $1.0 Billion Key SuppliersKey Suppliers At a Glance Packaging 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% 2006 2007 2008 2009 2010 2011 2015 Operating Income % of Sales ROICROIC Expanding ProfitsExpanding Profits 15.3% 18.4% 22.4% 30.0% 39.2% 48.6% 2006 2007 2008 2009 2010 2011 Target 6 – 7.5% Page 78 Value Proposition and Transformation Highlights Value Proposition • North America-based distributor with expanding global reach providing key plastic processors and market segments with best-in-class suppliers products, service and delivery with a commitment to develop value-added solutions to enhance customer profitability Transformation Highlights • Significant market share gains with key suppliers , > $5B Addressable Market • Significant market share gains with key suppliers � Proprietary PolyOne technology � Dow Corning • Improved sales mix and profitability by shifting to non-cyclical businesses like healthcare • Established presence in Brazil and Asia in 2011 Page 79 Key Differentiators • Product offering � Breadth and depth; industry leading suppliers • Sales and marketing capability • Customer service / logistics operations � Customer survey results – consistent best-in-class performance � Leading on-time delivery • Management team experience and stability • Lean Six Sigma � Solving our customers’ unmet needs Page 80 $102.8 $207.2 Healthcare Revenue • Strong market segmentation provides focused resourcing to accelerate growth • Expanding global reach meets Areas of Focus $66.0 $182.4 National Accounts Revenue • Expanding global reach meets customers’ needs and creates competitive differentiation • Selling skills & product application knowledge to target executives & engineers ($ millions) Page 81 Critical Imperatives • Invest in commercial resources to accelerate growth • Expand healthcare and key account revenues • Broaden geographic reach and develop new markets and channel partnerships Critical Imperatives and 2015 Goal channel partnerships • Continue to improve working capital efficiency and superior cash flow generation 2015 Goal • 6 - 7.5% return on sales Page 82 Page 83

Syncure™ XLPE Cross-linkable Polyethylene Formulations FOR LOW VOLTAGE CABLES PRODUCT SELECTION GUIDE Syncure™ XLPE MOISTURE CROSS-LINKABLE POLYETHYLENE INSULATION FOR LOW VOLTAGE CABLE SYSTEMS SYSTEM S100FH S100FH-XUV S100FH-UV S100FV S100FV-UV S112NA S120NA S200FH S200FV Applications Building Wire, Building Wire, Photo-Voltaic (PV) Wire Building Wire, Teck-90 Pipe and Tube Building Wire, Tray Cable, Service Entrance Building Wire, Tray Cable, Service Entrance Specification UL 44 UL 44 UL 44, UL 4703 UL 44 UL 44 CSA 22.2 Suitable for NSF 61 UL 44 UL 44 Wire Type XHHW-2, RHW-2, USE-2, XHHW-2, RHW-2, USE-2, SIS XHHW-2, RHW-2, USE-2, SIS, PV XHHW-2, RHW-2, XHHW-2, RHW-2, USE-2, SIS, PV RW-90, Teck-90 – RHW-2, RHW, RHH, XHHW-2, XHH, XHHW, SIS RHW, RHH, RHW-2 Components % 83% S1054A 17% V0022G RoHS 83% S1054A 17% V0022G-UV RoHS 70% S1054A 30% V0022G-UV RoHS 50% S1054A 50% V0044G RoHS 50% S1054A 50% V0044G-UV RoHS 95% S1054A 5% S1000B 95% S1016A 5% S1037B 78% S1054A 22% SC5400-0002 RoHS MB ALT FR 50% S1054A 50% SC5400-0003 RoHS MB ALT FR Features Horizontal Flame Horizontal Flame, UV Resistant, Colors Possible Horizontal Flame, FV-1 Flame, UV Resistant, Colors Possible VW-1 VW-1, UV Resistant, Colors Possible Non-FR Rigid Pipe Applications Horizontal Flame, DBDPE-free VW-1, DBDPE-free GENERAL PROPERTIES Specific Gravity 1.01 1.02 1.10 1.31 1.31 0.92 0.95 1.01 1.31 Hardness Shore D, 10 Seconds 47 47 47 48 48 47 59 47 48 Gel 68 68 70 70 70 72 72 68 70 TENSILE PROPERTIES Tensile Strength (psi) 2800 2500 2650 3200 2650 2800 4500 2800 3200 Elongation % 400 400 540 470 540 400 80 400 470 Tensile Retention % 100 100 97 110 110 95 75 95 100 Elongation Retention % 90 90 94 100 100 90 75 90 93 ELECTRICAL Dielectric Strength (V/mil) 1000 1400 1400 1200 1200 1000 – 1000 1200 Dielectric Constant 2.31 2.45 2.61 2.61 2.61 2.24 2.1 2.31 2.61 Dissipation Factor % 0.0012 0.0080 0.008 0.0043 0.0043 0.0008 0.002 0.0012 0.0043 THERMAL Temperature Rating °C 90 90 90 90 90 90 125 90 90 Heat Deformation % 10 5 5 5 5 10 10 10 5 The Syncure™ XLPE portfolio is a two-step, silane- grafted, moisture cross-linkable polyethylene system.

Long glass fiber formulations using this environmental stabilization technology resolve such aesthetic concerns by providing a smooth, fiber-free finish that is perfect for bringing structural parts out of hiding. Complēt moisture resistant nylons reinforced with long glass fiber produce a smooth, fiber-free finish without special processing to give molded components a high-quality appearance.

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number reducing risk of change • Non-phthalate and formulated without animal- derived substances • Available for use in a wide range of polymers including polyolefins, styrenics, polycarbonate and alloys, polyester, POM • Functionality can be combined with colorants into convenient combination concentrates and ready-to-use formulations REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request FUNCTIONALITY TARGET APPLICATIONS DRUG DELIVERY DEVICES SYRINGES & NEEDLES DIAGNOSTICS CATHETERS Clarifying PP Sorbitol-free for transparent applications with reduced migration and improved thermal stability     Lubricant— permanent/ non-migrating Fast acting reduction in friction for wide variety of polymers such as PP, ABS, POM, PC Protection from UV in transparent applications for PP, PE, PETG, COP UV blocking in 290-450nm with no impact on clarity; can be combined with colors (e.g., amber)   Antistatic ready-to- use solution for PP, ABS, PC/ABS Permanent/non-migrating; fast decay time independent of % relative humidity  Gamma/e-beam sterilization protection of the polymer Preserving the properties of PP and COC/COP; reduction in yellowing using Color Compensation Technology (CCT) Reduced material consumption/cycle time—nucleation Fast acting new generation nucleant for PE and PP; improved thermal and mechanical properties allows wall thinning; reduction of tolerance/dimensional problems between different colors Laser marking replacing ink printing/labels Solvent-free, high-speed identification for Nd/YAG laser for PE,PP, ABS, PC, POM     Antioxidants for PE, PP, TPE Thermal protection during converting/downstream sterilization    Brand protection/ anticounterfeit Covert and non-covert systems   Healthcare use limitations apply—see below.

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal- derived substances • Available for use in a wide range of polymers including polyolefins, styrenics, polycarbonate and alloys, polyester, POM • Functionality can be combined with colorants into convenient combination concentrates or formulations REGULATORY SUPPORT • Pre-tested raw materials: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request FUNCTIONALITY TARGET APPLICATIONS EBM/IBM CONTAINERS CLOSURES FILM COMBINATION DEVICES Clarifying PP Sorbitol-free—possibilities in packaging ocular solutions    Slip/torque reduction Slip for PE, PP films, processing aid, torque reduction for closures   Protection from UV in transparent packaging for PP, PE, PETG, COP UV blocking in 290–450nm with no impact on clarity    Antistatic ready-to-use solution for PE films e.g. Reduction in yellowing using Color Compensation Technology (CCT)   Reduced material consumption/cycle time/improved properties—nucleation Fast acting new generation nucleant for PE and PP; improved dimensional stability, thermal and mechanical properties    Laser marking replacing ink printing/labels Solvent-free, high-speed identification for Nd/YAG laser    Antiblock for PE/PP film Non-migrating additive system maintaining high gloss and printability  Antioxidants for PE, PP, TPE Thermal protection during converting/ downstream sterilization     Brand protection/ anticounterfeit Range of covert and non-covert systems    Volatiles/odor absorber for PE/PP Physical absorption of a wide range of molecules responsible for odor, VOC and potential extractables/ leachables in plastics   Healthcare use limitations apply—see below.

If any further information beyond included content is needed, feel free to contact us. Contact the appropriate account representative to negotiate specifics. 2. 1 – 2 days A6 If you answered “Yes” to Question (A1), does the plan account for interdependencies both internal and external to your organization?

Non-GAAP Financial Measures The Company uses both GAAP (generally accepted accounting principles) and non-GAAP financial measures. Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 20.8 $ 0.23 $ 64.4 $ 0.70 Special items, after tax (Attachment 3) 22.3 0.24 6.4 0.07 Amortization expense, after-tax 15.1 0.16 10.8 0.12 Adjusted net income / EPS $ 58.2 $ 0.63 $ 81.6 $ 0.89 8 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended March 31, 2023 2022 Sales $ 845.7 $ 892.2 Cost of sales 598.1 637.8 Gross margin 247.6 254.4 Selling and administrative expense 190.5 152.2 Operating income 57.1 102.2 Interest expense, net (28.8) (16.9) Other income (expense), net 0.7 (0.6) Income from continuing operations before income taxes 29.0 84.7 Income tax expense (7.7) (20.0) Net income from continuing operations 21.3 64.7 (Loss) income from discontinued operations, net of income taxes (0.9) 19.8 Net income 20.4 84.5 Net income attributable to noncontrolling interests (0.5) (0.3) Net income attributable to Avient common shareholders $ 19.9 $ 84.2 Earnings (loss) per share attributable to Avient common shareholders - Basic: Continuing operations $ 0.23 $ 0.70 Discontinued operations (0.01) 0.22 Total $ 0.22 $ 0.92 Earnings (loss) per share attributable to Avient common shareholders - Diluted: Continuing operations $ 0.23 $ 0.70 Discontinued operations (0.01) 0.21 Total $ 0.22 $ 0.91 Cash dividends declared per share of common stock $ 0.2475 $ 0.2375 Weighted-average shares used to compute earnings per common share: Basic 91.0 91.5 Diluted 91.8 92.3 9 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended March 31, 2023 2022 Cost of sales: Restructuring costs, including accelerated depreciation $ (6.6) $ (4.4) Environmental remediation costs (1.4) (2.0) Reimbursement of previously incurred environmental costs — 0.6 Impact on cost of sales (8.0) (5.8) Selling and administrative expense: Restructuring, legal and other (15.7) 1.9 Acquisition related costs (3.4) (2.9) Impact on selling and administrative expense (19.1) (1.0) Impact on operating income (27.1) (6.8) Other income (loss), net (0.2) 0.1 Impact on income from continuing operations before income taxes (27.3) (6.7) Income tax expense (benefit) on above special items 6.9 1.8 Tax adjustments(2) (1.9) (1.5) Impact of special items on net income from continuing operations $ (22.3) $ (6.4) Diluted earnings per common share impact $ (0.24) $ (0.07) Weighted average shares used to compute adjusted earnings per share: Diluted 91.8 92.3 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results 2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and changes to valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) March 31, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 582.7 $ 641.1 Accounts receivable, net 484.4 440.6 Inventories, net 371.9 372.7 Other current assets 125.3 115.3 Total current assets 1,564.3 1,569.7 Property, net 1,045.7 1,049.2 Goodwill 1,689.7 1,671.9 Intangible assets, net 1,601.7 1,597.6 Other non-current assets 209.8 196.6 Total assets $ 6,111.2 $ 6,085.0 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term debt $ 2.2 $ 2.2 Accounts payable 448.1 454.4 Accrued expenses and other current liabilities 386.9 412.8 Total current liabilities 837.2 869.4 Non-current liabilities: Long-term debt 2,177.7 2,176.7 Pension and other post-retirement benefits 66.2 67.2 Deferred income taxes 332.5 342.5 Other non-current liabilities 329.0 276.4 Total non-current liabilities 2,905.4 2,862.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,349.8 2,334.5 Noncontrolling interest 18.8 18.3 Total equity 2,368.6 2,352.8 Total liabilities and equity $ 6,111.2 $ 6,085.0 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Three Months Ended March 31, 2023 2022 Operating Activities Net income $ 20.4 $ 84.5 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 48.7 35.7 Accelerated depreciation 1.8 2.1 Share-based compensation expense 3.2 3.2 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (40.2) (118.8) Decrease (increase) in inventories 3.8 (15.1) (Decrease) increase in accounts payable (9.9) 90.5 Accrued expenses and other assets and liabilities, net (50.0) (63.2) Net cash (used) provided by operating activities (22.2) 18.9 Investing activities Capital expenditures (20.3) (13.3) Net proceeds from divestiture 7.3 — Net cash used by investing activities (13.0) (13.3) Financing activities Purchase of common shares for treasury — (15.8) Cash dividends paid (22.5) (21.7) Repayment of long-term debt (0.8) (2.4) Other financing (2.3) (3.9) Net cash used by financing activities (25.6) (43.8) Effect of exchange rate changes on cash 2.4 (0.4) Decrease in cash and cash equivalents (58.4) (38.6) Cash and cash equivalents at beginning of year 641.1 601.2 Cash and cash equivalents at end of period $ 582.7 $ 562.6 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Corporate seat Amsterdam First entry in Business Register 12-04-2006 Date of deed of incorporation 11-04-2006 Date of deed of last amendment to the Articles of Association 12-04-2021 Issued capital EUR 19.593,63 Paid-up capital EUR 19.593,63 Filing of the annual accounts The annual accounts for the financial year 2019 were filed on 01-07-2020.

Confidential 4 Avient IT Department Information Systems Use Policy September 1, 2021 Additionally, the following Information Systems uses are prohibited unless specifically authorized by Avient or authorized Avient IT representatives: • Revealing account usernames, passwords, or other Personal Data to others or allowing use of Information Systems by others, including family and other household members; • Conducting any form of network monitoring that could intercept data not intended for the recipient User; • Circumventing User authentication or security of any Information Systems; or • Using personal devices to access Confidential Data or connect to Information Systems. For example, Personal Data could be an individual’s Social Security Number (SSN), name, address, date of birth, tax identification number or equivalent, credit or debit card number, or financial account number. Personal Data additionally includes any non-Avient data of a private nature, such as login information for personal email, social media, or subscription service accounts, personal documents, and notes.